Rafina Innovations Inc.

OTCPK:VICA Stock Report

Market Cap: US$13.9k

Rafina Innovations Past Earnings Performance

Past criteria checks 0/6

There is insufficient data on Rafina Innovations's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare Industry Growth8.5%
Revenue growth raten/a
Return on equityn/a
Net Marginn/a
Last Earnings Update31 Mar 2019

Recent past performance updates

No updates

Recent updates

No updates

In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Rafina Innovations has not provided sufficient past data to assess its track record.

This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.

Show section

Revenue & Expenses Breakdown

How Rafina Innovations makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:VICA Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 190-640
31 Dec 180-640
30 Sep 180-521
30 Jun 180-521
31 Mar 180-321
31 Dec 170-321
30 Sep 170-220
30 Jun 171-110
31 Mar 171-110
31 Dec 161-220
30 Sep 161-220
30 Jun 160-330
31 Mar 160-1035
31 Dec 150-925
30 Sep 150-2526
30 Jun 150-2516
31 Mar 150-1912
31 Dec 140-1903
30 Sep 140-422
30 Jun 140-322
31 Mar 140-211
31 Dec 130-110
30 Sep 130000

Quality Earnings: Insufficient data to determine if VICA has high quality earnings.

Growing Profit Margin: Insufficient data to determine if VICA's profit margins have improved over the past year.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if VICA's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare VICA's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if VICA's earnings growth over the past year exceeded the Healthcare industry average.


Return on Equity

High ROE: VICA has a negative Return on Equity (0%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.